134 related articles for article (PubMed ID: 20036564)
21. Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stability.
Hovlid ML; Edelstein RL; Henry O; Ochocki J; DeGraw A; Lenevich S; Talbot T; Young VG; Hruza AW; Lopez-Gallego F; Labello NP; Strickland CL; Schmidt-Dannert C; Distefano MD
Chem Biol Drug Des; 2010 Jan; 75(1):51-67. PubMed ID: 19954434
[TBL] [Abstract][Full Text] [Related]
22. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
[No Abstract] [Full Text] [Related]
23. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity.
Minutolo F; Bertini S; Betti L; Di Bussolo V; Giannaccini G; Placanica G; Rapposelli S; Spielmann HP; Macchia M
Farmaco; 2003 Dec; 58(12):1277-81. PubMed ID: 14630239
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
Devreux V; Wiesner J; Goeman JL; Van der Eycken J; Jomaa H; Van Calenbergh S
J Med Chem; 2006 Apr; 49(8):2656-60. PubMed ID: 16610809
[TBL] [Abstract][Full Text] [Related]
26. The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity.
Xu L; Tao S; Wang X; Yu Z; Wang M; Chen D; Jing Y; Dong J
Bioorg Med Chem; 2006 Aug; 14(15):5351-6. PubMed ID: 16617020
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activity of enantiomers of antitumor irofulven.
McMorris TC; Staake MD; Kelner MJ
J Org Chem; 2004 Feb; 69(3):619-23. PubMed ID: 14750783
[TBL] [Abstract][Full Text] [Related]
28. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate.
Long SB; Casey PJ; Beese LS
Biochemistry; 1998 Jul; 37(27):9612-8. PubMed ID: 9657673
[TBL] [Abstract][Full Text] [Related]
29. Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials.
Opsenica I; Opsenica D; Smith KS; Milhous WK; Solaja BA
J Med Chem; 2008 Apr; 51(7):2261-6. PubMed ID: 18330976
[TBL] [Abstract][Full Text] [Related]
30. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
Gupta MK; Prabhakar YS
Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
[TBL] [Abstract][Full Text] [Related]
31. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Wiemer AJ; Yu JS; Lamb KM; Hohl RJ; Wiemer DF
Bioorg Med Chem; 2008 Jan; 16(1):390-9. PubMed ID: 17905588
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of frame-shifted farnesyl diphosphate analogs.
Placzek AT; Hougland JL; Gibbs RA
Org Lett; 2012 Aug; 14(16):4038-41. PubMed ID: 22857735
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and activity of fluorescent isoprenoid pyrophosphate analogues.
Kim M; Kleckley TS; Wiemer AJ; Holstein SA; Hohl RJ; Wiemer DF
J Org Chem; 2004 Nov; 69(24):8186-93. PubMed ID: 15549786
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of derrubone and select analogues.
Hastings JM; Hadden MK; Blagg BS
J Org Chem; 2008 Jan; 73(2):369-73. PubMed ID: 18154304
[TBL] [Abstract][Full Text] [Related]
37. Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy.
da Silva CH; da Silva VB; Resende J; Rodrigues PF; Bononi FC; Benevenuto CG; Taft CA
J Mol Graph Model; 2010 Feb; 28(6):513-23. PubMed ID: 20074987
[TBL] [Abstract][Full Text] [Related]
38. New asymmetric synthesis of protein farnesyltransferase inhibitors via palladium-catalyzed cross-coupling reactions of 2-iodo-imidazoles.
Kerhervé J; Botuha C; Dubois J
Org Biomol Chem; 2009 May; 7(10):2214-22. PubMed ID: 19421463
[TBL] [Abstract][Full Text] [Related]
39. Didehydrofarnesyl diphosphate: an intrinsically fluorescent inhibitor of protein farnesyltransferase.
Liu XH; Prestwich GD
Bioorg Med Chem Lett; 2004 May; 14(9):2137-40. PubMed ID: 15080995
[TBL] [Abstract][Full Text] [Related]
40. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
